Shuting Yu
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 7
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 5
- Gut microbiota and health 4
- Co-authors
- Rocky S. Tuan (5 shared papers)Hang Lin (2 shared papers)Benjamin B. Rothrauff (2 shared papers)Guang Yang (1 shared paper)Weijie Du (8 shared papers)Ping Pang (6 shared papers)Yu Bian (5 shared papers)Xin Li (2 shared papers)
- Journals
- Scientific Reports (3 papers)Frontiers of Medicine (3 papers)Cell Discovery (2 papers)Acta Pharmacologica Sinica (2 papers)Journal of Molecular and Cellular Cardiology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shuting Yu
57 papers receiving 2.5k citations
Shuting Yu's Hit Papers
Peers
Comparison fields: 5 of 141
- Infectious Diseases 555
- Cancer Research 320
- Parasitology 133
- Molecular Biology 868
- Orthopedics and Sports Medicine 98
Countries citing papers authored by Shuting Yu
This map shows the geographic impact of Shuting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Yu more than expected).
Fields of papers citing papers by Shuting Yu
This network shows the impact of papers produced by Shuting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Yu. The network helps show where Shuting Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuting Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Viral and host factors related to the clinical outcome of COVID-19 Hit paper breakdown → | 2020 | 678 |
| 2 | 2013 | 243 | |
| 3 | 2015 | 228 | |
| 4 | 2016 | 190 | |
| 5 | 2019 | 130 | |
| 6 | 2022 | 94 | |
| 7 | 2023 | 86 | |
| 8 | 2019 | 81 | |
| 9 | 2016 | 57 | |
| 10 | 2022 | 52 | |
| 11 | 2017 | 46 | |
| 12 | 2015 | 46 | |
| 13 | 2024 | 43 | |
| 14 | 2023 | 40 | |
| 15 | 2017 | 38 | |
| 16 | 2017 | 37 | |
| 17 | 2021 | 37 | |
| 18 | 2021 | 33 | |
| 19 | 2020 | 31 | |
| 20 | 2024 | 29 |
About Shuting Yu
Shuting Yu is a scholar working on Cancer Research, Molecular Biology, Otorhinolaryngology, Infectious Diseases and Oncology, having authored 60 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Circular RNAs in diseases (5 papers), COVID-19 Clinical Research Studies (4 papers), Head and Neck Cancer Studies (4 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Infectious Diseases (555 citations), Cancer Research (320 citations), Parasitology (133 citations), Molecular Biology (868 citations) and Orthopedics and Sports Medicine (98 citations). Shuting Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rocky S. Tuan, Hang Lin, Benjamin B. Rothrauff, Guang Yang, Weijie Du, Ping Pang, Yu Bian, Xin Li, Baofeng Yang and Yimin Song. Their work appears in journals such as Scientific Reports, Frontiers of Medicine, Cell Discovery, Acta Pharmacologica Sinica and Journal of Molecular and Cellular Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.